Guilherme Nader Marta (Guilherme Nader-Marta)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Respiratory Syndrome Coronavirus

Early Breast Cancer

Immune Response

Metastatic Renal Cell Carcinoma

Top Venues

JCO global oncology

Clinics (Sao Paulo, Brazil)

Nature medicine

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Guilherme Nader Marta, Chiara Molinelli, Veronique Debien, Diogo Martins-Branco, Philippe Aftimos, Evandro de Azambuja, Ahmad Awada
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment. Therapeutic advances in medical oncology 15 (2023)
Diogo Martins-Branco, Guilherme Nader Marta, Andrea Gombos, Philippe Barthelemy, Anthony Goncalves, Edith Borcoman, Florian Clatot, Stephane Holbrechts, Eleonora De Maio D'Esposito, Claire Cheymol, Vincent Vanhaudenarde, Fran Ois P Duhoux, Caroline Duhem, Lore Decoster, Hannelore G Denys, Florence Lefranc, Jean-Luc Canon, Paul M Clement, Joseph Gligorov, Marianne Paesmans, Nadège Kindt, Ahmad Awada, Nuria Kotecki
BrainStorm: a multicenter international study to tackle CNS metastases in solid tumors. Nature medicine (2023)
Diogo Martins-Branco, Guilherme Nader Marta, Ana Tečić Vuger, Veronique Debien, Lieveke Ameye, Mariana Brandão, Kevin Punie, Angela Loizidou, Karen Willard-Gallo, Chloe Spilleboudt, Ahmad Awada, Martine J Piccart, Evandro de Azambuja
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis. Journal of cancer research and clinical oncology (2022)
Elisa Agostinetto, Agnese Losurdo, Guilherme Nader Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja, Matteo Lambertini
Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer. Expert opinion on investigational drugs 31 (6) (2022)
Elisa Agostinetto, Guilherme Nader Marta, Marianne Paesmans, Lieveke Ameye, Isabelle Veys, Laurence Buisseret, Patrick Neven, Donatienne Taylor, Christel Fontaine, Francois P Duhoux, Jean-Luc Canon, Hannelore Denys, Florence Coussy, Camille Chakiba, Joana Mourato Ribeiro, Martine Piccart, Christine Desmedt, Michail Ignatiadis, Philippe Aftimos
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast. Future oncology (London, England) 18 (22) (2022)
Guilherme Nader Marta, Véronique Debien, Daniel Eiger, Zoi Tsourti, Rafael Caparica, Marie Kassapian, Sylvia Napoleone, Susanne Hultsch, Larissa Korde, Yingbo Wang, Saranya Chumsri, Kathleen I Pritchard, Michael Untch, Meritxell Bellet-Ezquerra, Daniela Dornelles Rosa, Alvaro Moreno-Aspitia, Martine Piccart, Urania Dafni, Evandro de Azambuja
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study. British journal of cancer 127 (10) (2022)
Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, Gabriel Watarai, Maria Cecilia Mathias Machado, Lorena Teixeira Frasson, Camila Motta Venchiarutti Moniz, Raquel Keiko de Luca Ito, Driele Peixoto Bittencourt, Camilla O Hoff, Veruska Menegatti Anastacio, Ulysses Ribeiro Junior, Juliana Pereira, Vanderson Rocha, Edson Abdala, Maria Del Pilar Estevez-Diz, Paulo Marcelo Gehm Hoff
Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19. JCO global oncology 7 (2021)
Guilherme Nader Marta, Leonardo Gomes da Fonseca, Maria Ignez Freitas Melro Braghiroli, Fernando Moura, Paulo Marcelo Gehm Hoff, Jorge Sabbaga
Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma. Clinics (Sao Paulo, Brazil) 76 (2021)
Guilherme Nader Marta, Rodrigo Ramella Munhoz, Monica La Porte Teixeira, Bernadette Cunha Waldvogel, Veridiana Pires de Camargo, Olavo Feher, Jose Antonio Sanches
Trends in Melanoma Mortality in Brazil: A Registry-Based Study. JCO global oncology 6 (2021)
Guilherme Nader Marta, Pedro Isaacsson Velho, Renata R C Bonadio, Mirella Nardo, Sheila F Faraj, Manoel Carlos L de Azevedo Souza, David Q B Muniz, Diogo Assed Bastos, Carlos Dzik
Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma. Pathology oncology research : POR 26 (4) (2020)